Appendectomy and Colorectal Cancer
Altered Gut Microbiome Composition by Appendectomy Contributes to Colorectal Cancer
1 other identifier
observational
180,000
1 country
1
Brief Summary
Colorectal cancer (CRC) is one of the most common cancer worldwide. Initiation and progression of CRC involve complex interactions among genetic, epigenetic and environmental factors. Given that hereditary and familial CRC only accounts for 2% to 5% of cases, environmental factors are the key triggers of CRC. Emerging evidence has indicated that gut microbes are an important environmental factor promoting CRC development. Gut dysbiosis has been shown to promote colorectal carcinogenesis in mice. Several individual bacterial species, such as the enterotoxigenic Bacteroides fragilis (ETBF), Fusobacterium nucleatum and Peptostreptococcus anaerobius, could exert carcinogenic effects by inducing direct DNA damage, oxidative damage and activating oncogenic signaling pathways. Recent studies have shown that the appendix plays an important role in maintaining homeostasis and biodiversity of gut microbiome by providing an ideal ecological niche for commensal bacteria and production of immunoglobulin A. Considering the key role of microorganisms in gastrointestinal pathophysiology, absence of appendix may result in disruption of microbiome homeostasis, which could potentially influence the risk of developing CRC. In terms of epidemiological evidence, the association of appendectomy with the risk of CRC development has been controversial, and to date no consensus has been attained. Although gut microorganisms could be a crucial pivot between appendectomy and risk of subsequent CRC development, the direct contribution of appendectomy and the underlying mechanisms are still largely unexplored. In this study, we aim to study
- 1.the association between appendectomy and colorectal cancer, and
- 2.the role of appendectomy in CRC risk through causing gut microbial dysbiosis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jun 2022
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2022
CompletedFirst Submitted
Initial submission to the registry
October 8, 2023
CompletedFirst Posted
Study publicly available on registry
October 19, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 31, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
May 31, 2025
CompletedOctober 19, 2023
October 1, 2023
3 years
October 8, 2023
October 14, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
Appendectomy is associated with risk of subsequent CRC incidence
Individuals underwent appendectomy from January 2000 to December 2020 will be retrieved from a population-based database (CDARS) in Hong Kong. For the control group, individuals without appendectomy between 2000 and 2020 based on the same exclusion criteria will be identified from the total population register of CDARS. For each case of appendectomy, we will select two matched referential individuals from the pool based on the year of birth and gender to study the association between appendectomy and CRC risk.
3 years
Study Arms (2)
Non-appendectomy controls
Appendectomy cases
Eligibility Criteria
60000 appendectomy cases and 120000 controls
You may qualify if:
- Individuals underwent appendectomy from January 2000 to December 2020
You may not qualify if:
- patients with the age ≤18 years at enrollment;
- Patients with any malignant diseases or inflammatory bowel disease history before enrollment;
- Patients with hereditary syndromes of colorectal adenomas or polyps (familial adenomatous polyposis, Lynch syndrome, etc.);
- Patients that underwent appendectomy for appendiceal neoplasms.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Institute of Digestive Disease, The Chinese University of Hong Kong
Shatin, 00000, Hong Kong
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
October 8, 2023
First Posted
October 19, 2023
Study Start
June 1, 2022
Primary Completion
May 31, 2025
Study Completion
May 31, 2025
Last Updated
October 19, 2023
Record last verified: 2023-10